Total planned funding: $114,072,142
Allocations
Countries/Regions
India | $114,072,142 |
Organizational Types
Unknown | $40,837,036 |
NGO | $37,822,216 |
Own Agency | $20,294,495 |
University | $8,791,895 |
Multi-lateral Agency | $2,860,000 |
FBO | $1,600,000 |
Private Contractor | $900,000 |
Other USG Agency | $627,300 |
Host Country Government Agency | $339,200 |
Implementing Agency | $0 |
Program Areas
Governance and Systems | $36,869,752 |
Prevention | $32,106,637 |
Care | $16,412,137 |
Management and Operations | $13,816,036 |
Testing | $7,455,922 |
Treatment | $7,411,658 |
Budget Codes
OHSS: Health Systems Strengthening | $17,473,518 |
HVOP: Sexual Prevention: Other Sexual Prevention | $17,419,821 |
HVSI: Strategic Information | $15,378,492 |
HVMS: Management and Operations | $13,816,036 |
HBHC: Care: Adult Care and Support | $10,023,908 |
HVCT: Testing: HIV Testing and Counseling | $7,455,922 |
HTXS: Treatment: Adult Treatment | $6,950,163 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,240,985 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,106,472 |
HLAB: Laboratory Infrastructure | $4,017,742 |
HVTB: Care: TB/HIV | $3,260,030 |
HKID: Care: Orphans and Vulnerable Children | $2,564,876 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $2,029,706 |
HMBL: Biomedical Prevention: Blood Safety | $1,299,653 |
PDCS: Care: Pediatric Care and Support | $563,323 |
PDTX: Treatment: Pediatric Treatment | $438,018 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$40,212,547
Countries/Regions
FHI 360:
$14,851,228
Countries/Regions
USG Aggregated Agencies:
$10,603,290
Countries/Regions
Voluntary Health Services:
$7,550,000
Countries/Regions